Latest filing published 26 Jan 2021 for Prevail Therapeutics Inc..
Insider track record
No signal scores available.
Emily Minkow: trading record in brief
All filings by Emily Minkow on record concern Prevail Therapeutics Inc. Over a trading history stretching from 24 December 2019 to 22 January 2021, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 26 January 2021 with a transaction in Prevail Therapeutics Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Emily Minkow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,000 sharesCommon StockSEC:0001209191-21-005432:0
- 13,000 shares@ US$0.18100.0% of flowCommon StockSEC:0001209191-20-018117:0
2 of 2 declarations
